VTL Share Price Performance
AU$0
0.00 (0.00%)
Price AU$0
Share Pricen/a
VGI Health Technology Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
VTL Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
VGI Health Technology Limited Key Details
Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
- -0.011
- 15.69%
- -6,186.86%
- -393.5%
About VTL
- Founded
- 2004
- Employees
- n/a
- CEO
- WebsiteView website
VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies. It offers drugs and wellbeing supplements. The company also develops nE1-Heart for treatment of hyperlipidaemia; and nE1-Elite that reduce delayed onset muscle soreness, enhance muscle recovery, and provide exercise endurance and maintenance of muscle power. In addition, it develops therapeutic drug development program for various indications, such as unmet needs, non-alcoholic fatty liver diseases/nonalcoholic steatohepatitis, and pancreatic cancer. The company was formerly known as Azure Health Technology Limited and changed its name to VGI Health Technology Limited in July 2021. VGI Health Technology Limited was incorporated in 2004 and is based in Lane Cove, Australia.
